Articles citing ScienceDirect

Study Reveals CBN's Potential in Neuroprotection

2 Sources

Salk Institute researchers have discovered that CBN, a lesser-known cannabinoid with neuroprotective properties, could lead to future therapies for neurodegenerative diseases and brain injury prevention. The search for effective treatments for neurodegenerative diseases has long been a challenge, particularly as the global population ages and the prevalence of conditions like Alzheimer’s and Parkinson’s continues to rise. However, recent research from the Salk Institute offers a glimmer of hope, focusing on a lesser-known cannabinoid, cannabinol (CBN), and its potential to protect the brain against aging and neurodegeneration.

Read article

Sources from ScienceDirect

Image 1

ScienceDirect ScienceDirect

Cited in: Study Reveals CBN's Potential in Neuroprotection

Fragment-based drug discovery and biological evaluation of novel cannabinol-based inhibitors of oxytosis/ferroptosis for neurological disorders

39min read

The oxytosis/ferroptosis regulated cell death pathway is an emerging field of research owing to its pathophysiological relevance to a wide range of neurological disorders, including Alzheimer's and Parkinson's diseases and traumatic brain injury.